⌘K

Login Start Free

Home/Filings/4/0001062993-24-020468

4//SEC Filing

BUCHI J KEVIN 4

Accession 0001062993-24-020468

CIK 0001808898other

View on SEC.gov Company Profile

Filed

Dec 10, 7:00 PM ET

Accepted

Dec 11, 5:22 PM ET

Size

5.1 KB

Accession

0001062993-24-020468

Insider Transaction Report

Form 4

Period: 2024-12-09

Benitec Biopharma Inc.BNTC

Director

Transactions

Award
Options (right to buy)
2024-12-09+35,000→ 35,000 total
Exercise: $12.18Exp: 2034-12-09→ Common Stock (35,000 underlying)

Footnotes (1)

[F1]The stock options will vest on the earlier of the Issuer's next annual stockholders' meeting or December 9, 2025.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Benitec Biopharma Inc.

CIK 0001808898

Entity typeother

Related Parties

1

filerCIK 0001209726

Filing Metadata

Form type: 4
Filed: Dec 10, 7:00 PM ET
Accepted: Dec 11, 5:22 PM ET
Size: 5.1 KB

View on SEC.gov